Compile Data Set for Download or QSAR
maximum 50k data
Found 141 Enz. Inhib. hit(s) with all data for entry = 7682
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92800(Bisanilinopyrimidine, 3o | US9249124, 16)
Affinity DataIC50:  0.800nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92800(Bisanilinopyrimidine, 3o | US9249124, 16)
Affinity DataIC50:  0.800nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92835(Bisanilinopyrimidine, 9h | US9249124, 51)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92840(Bisanilinopyrimidine, 9l | US9249124, 56)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92836(Bisanilinopyrimidine, 6p | US9249124, 52)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92837(Bisanilinopyrimidine, 9i | US9249124, 53)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92841(Bisanilinopyrimidine, 9m | US9249124, 57)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92838(Bisanilinopyrimidine, 9j | US9249124, 54)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92839(Bisanilinopyrimidine, 9k | US9249124, 55)
Affinity DataIC50: <1nMT: 2°CAssay Description:Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92810(Bisanilinopyrimidine, 6c | US9249124, 26)
Affinity DataIC50:  2nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87054(Bisanilinopyrimidine inhibitor, 8 | Bisanilinopyri...)
Affinity DataIC50:  2.10nM Kd:  13nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87054(Bisanilinopyrimidine inhibitor, 8 | Bisanilinopyri...)
Affinity DataIC50:  2.10nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87054(Bisanilinopyrimidine inhibitor, 8 | Bisanilinopyri...)
Affinity DataIC50:  2.10nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87053(Bisanilinopyrimidine inhibitor, 7 | Bisanilinopyri...)
Affinity DataIC50:  2.5nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87053(Bisanilinopyrimidine inhibitor, 7 | Bisanilinopyri...)
Affinity DataIC50:  2.5nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87053(Bisanilinopyrimidine inhibitor, 7 | Bisanilinopyri...)
Affinity DataIC50:  2.5nM Kd:  15nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM50004205(MK-045 | MK-0457 | TOZASERTIB | US9249124, VX680 |...)
Affinity DataIC50:  2.80nM Kd:  17nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM50004205(MK-045 | MK-0457 | TOZASERTIB | US9249124, VX680 |...)
Affinity DataIC50:  2.80nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92844(Bisanilinopyrimidine, 12b | US9249124, 60)
Affinity DataIC50:  2.90nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92846(Bisanilinopyrimidine, 12d | US9249124, 62)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92843(Bisanilinopyrimidine, 12a | US9249124, 59)
Affinity DataIC50:  3.10nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92843(Bisanilinopyrimidine, 12a | US9249124, 59)
Affinity DataIC50:  3.10nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92843(Bisanilinopyrimidine, 12a | US9249124, 59)
Affinity DataIC50:  3.10nM Kd:  18nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92805(Bisanilinopyrimidine, 4d | US9249124, 21)
Affinity DataIC50:  3.17nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92817(Bisanilinopyrimidine, 6j | US9249124, 33)
Affinity DataIC50:  3.30nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87052(Bisanilinopyrimidine inhibitor, 6 | Bisanilinopyri...)
Affinity DataIC50:  3.70nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87052(Bisanilinopyrimidine inhibitor, 6 | Bisanilinopyri...)
Affinity DataIC50:  3.70nM Kd:  16nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87052(Bisanilinopyrimidine inhibitor, 6 | Bisanilinopyri...)
Affinity DataIC50:  3.70nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92799(Bisanilinopyrimidine, 3n | US9249124, 15)
Affinity DataIC50:  3.90nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92812(Bisanilinopyrimidine, 6e | US9249124, 28)
Affinity DataIC50:  4nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM209949(US9249124, 43)
Affinity DataIC50:  4.5nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92803(Bisanilinopyrimidine, 3r | US9249124, 19)
Affinity DataIC50:  5.10nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87048(Bisanilinopyrimidine inhibitor, 2 | Bisanilinopyri...)
Affinity DataIC50:  6.10nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87048(Bisanilinopyrimidine inhibitor, 2 | Bisanilinopyri...)
Affinity DataIC50:  6.10nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87048(Bisanilinopyrimidine inhibitor, 2 | Bisanilinopyri...)
Affinity DataIC50:  6.10nM Kd:  34nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM209946(US9249124, 34)
Affinity DataIC50:  6.60nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92825(Bisanilinopyrimidine, 6r | US9249124, 41)
Affinity DataIC50:  8.5nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87047(Bisanilinopyrimidine inhibitor, 1 | Bisanilinopyri...)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87047(Bisanilinopyrimidine inhibitor, 1 | Bisanilinopyri...)
Affinity DataIC50:  10nM Kd:  39nMpH: 7.4Assay Description:The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM87047(Bisanilinopyrimidine inhibitor, 1 | Bisanilinopyri...)
Affinity DataIC50:  10nMpH: 7.4 T: 2°CAssay Description:Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultr...More data for this Ligand-Target Pair
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM16011(2-{[5-fluoro-2-(phenylamino)pyrimidin-4-yl]amino}b...)
Affinity DataIC50:  11.3nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92840(Bisanilinopyrimidine, 9l | US9249124, 56)
Affinity DataIC50:  12.3nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92841(Bisanilinopyrimidine, 9m | US9249124, 57)
Affinity DataIC50:  14.4nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92845(Bisanilinopyrimidine, 12c | US9249124, 61)
Affinity DataIC50:  17.3nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92830(Bisanilinopyrimidine, 9c | US9249124, 46)
Affinity DataIC50:  18nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92802(Bisanilinopyrimidine, 3q | US9249124, 18)
Affinity DataIC50:  18.3nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM209947(US9249124, 38)
Affinity DataIC50:  18.7nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92801(Bisanilinopyrimidine, 3p | US9249124, 17)
Affinity DataIC50:  19.9nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92842(Bisanilinopyrimidine, 9n | US9249124, 58)
Affinity DataIC50:  21.2nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
H. Lee Moffitt Cancer Center And Research Institute

US Patent
LigandPNGBDBM92838(Bisanilinopyrimidine, 9j | US9249124, 54)
Affinity DataIC50:  21.4nMpH: 7.4 T: 2°CAssay Description:Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v)...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 141 total ) | Next | Last >>
Jump to: